Pursuant to the transaction with Telix, ImaginAb has retained its lead imaging candidate, CD8 ImmunoPET, which is currently in Phase 2 clinical trials and has been licensed by numerous pharmaceutical ...
What is the objective of the UBS Australian Small Companies Fund managed fund? The objective of the UBS Australian Small Companies Fund managed fund is The Fund aims to outperform (after management ...